Filing Flows › Comparisons › HRTX vs AKBA
Heron Therapeutics vs Akebia Therapeutics: HRTX and AKBA compared
Heron Therapeutics is the larger company: $37.7M of revenue in its latest quarter (Q2 2026) against $36.9M for Akebia Therapeutics (Q3 2026). Heron Therapeutics is growing faster (+1% against -37% a year earlier). Heron Therapeutics is more profitable, with an operating margin of -5.4% against -31.1%.
Where the money goes: HRTX and AKBA
Heron Therapeutics (HRTX) · Q2 2026
Heron Therapeutics, Q2 2026: revenue $37.7M (+1% year over year), operating margin -5.4%, net loss $5.5M, operating cash flow −$2.2M. The chart follows the revenue to costs, profit and cash.
Akebia Therapeutics (AKBA) · Q3 2026
Akebia Therapeutics, Q3 2026: revenue $36.9M (-37% year over year), operating margin -31.1%, net loss $14.4M, operating cash flow $2.3M. The chart follows the revenue to costs, profit and cash.
| Heron Therapeutics (HRTX) | Akebia Therapeutics (AKBA) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $37.7M | $36.9M |
| Revenue growth, Y/Y | +1% | -37% |
| Operating margin | -5.4% | -31.1% |
| Net earnings | −$5.5M | −$14.4M |
| Net margin | -14.6% | -38.9% |
| Operating cash flow | −$2.2M | $2.3M |
| Free cash flow | — | $1.6M |
Where the revenue comes from
Heron Therapeutics
- CINVANTI: $21.8M (58%)
- ZYNRELEF: $11.1M (29%)
- Aponvie: $4.3M (11%)
- SUSTOL: $540K (1%)
Akebia Therapeutics
- Product revenue, net: $34.8M (94%)
- License, collaboration and other revenue: $2.1M (6%)
Questions
Which is bigger, Heron Therapeutics or Akebia Therapeutics?
Heron Therapeutics is the larger company: $37.7M of revenue in its latest quarter (Q2 2026) against $36.9M for Akebia Therapeutics (Q3 2026).
Is Heron Therapeutics or Akebia Therapeutics growing faster?
Heron Therapeutics is growing faster (+1% against -37% a year earlier).
Which is more profitable, Heron Therapeutics or Akebia Therapeutics?
Heron Therapeutics is more profitable, with an operating margin of -5.4% against -31.1%.
More: Heron Therapeutics earnings · how Heron Therapeutics makes money · Akebia Therapeutics earnings · how Akebia Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 10, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.